Manifestations of intraocular inflammation over time in patients on brolucizumab for neovascular AMD

PURPOSE: To describe the adverse events associated with brolucizumab, in particular the sequence of intraocular inflammation (IOI), retinal vasculitis (RV), and/or retinal vascular occlusion (RO). METHODS: This was an unmasked post hoc analysis of the randomized HAWK/HARRIER clinical trials. Patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoramnia, Ramin, Figueroa, Marta S., Hattenbach, Lars-Olof, Pavesio, Carlos E., Anderesi, Majid, Schmouder, Robert, Chen, Yu, de Smet, Marc D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Retinal Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061681/
https://www.ncbi.nlm.nih.gov/pubmed/34932153
http://dx.doi.org/10.1007/s00417-021-05518-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061681/
https://www.ncbi.nlm.nih.gov/pubmed/34932153
http://dx.doi.org/10.1007/s00417-021-05518-0

Ejemplares similares